BioRadious Therapeutics joins OVIS platform.
OVIS is the Indian national Cross Participation Platform for to obtain Clean Volunteers for BA BE studies has expanded its network in ndia.
Bioradius Therapeutics, has joined the OVIS platform. Bioradius shall be operating its studies from Pune, India.
OVIS offer Clean Volunteers for Risk Free studies based on the blood regeneration and drug washout parameters. The India wide Volunteers Eligibility Platform
OVIS has traced 1.3+ million In-eligible volunteers and has avoided Drug Reaction issues in them. Further OVIS has approved 2.5+ million volunteers for various studies across the country.
#OVIS #ClinicalResearch #CRO #LifeScience #ClinicalStudy #HumanVolunteers #CleanVolunteers #RiskFreeStudies #CrossParticipation #PhaseI #PhaseIII #EarlyStage #DrugTesting #ScreeningEligibility #DosingEligibility #RiskMitigation #HealthyVolunteers #LowCostStudies #SafeStudies #ADR #SADR #AvoidADR #DrugConcentration #RealTimeStatus #USFDA #CFR11 #BA #BE #PKStudies